Sanofi
$39.92Change from previous close: −1.84%Absolute change: −$0.75
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $95.65B
- Enterprise value
- $113.24B
- P/E (trailing 12 months)
- 22.2
- Forward P/E
- 7.39
- PEG
- 27.7
- Price/book
- 1.22
- Price/sales
- 1.96
- EV/EBITDA
- 8.36
- EV/revenue
- 2.32
Profitability and growth
- Gross margin
- 73.5%
- Operating margin
- 21.0%
- Net margin
- 8.1%
- ROE
- 5.7%
- ROA
- 5.1%
- ROIC
- 9.1%
- Revenue growth (year over year)
- 14.6%
- Earnings growth (year over year)
- -91.2%
Financial health
- Total cash
- $6.35B
- Total debt
- $23.58B
- Debt/equity
- 0.34
- Current ratio
- 0.99
- Quick ratio
- 0.49
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- $2.42
- Dividend yield
- 6.1%
- Payout ratio
- 128.2%
- Ex-dividend date
- May 4, 2026
Analysts and estimates
- Average price target
- $53.72
- Median price target
- $54.50
- High price target
- $63.00
- Low price target
- $45.00
- Analysts with a price target
- 9
- Consensus
- Buy
- Forward EPS
- $5.40
- EPS estimate, current year
- $5.02
Shares and trading
- Beta
- 0.28
- Average volume
- 2.9M
- Shares outstanding
- 2.4B
- Float
- 2.16B
- Institutional ownership
- 8.0%
- Insider ownership
- 0.0%
- Short interest (% of float)
- 0.4%
- Short ratio (days)
- 4.33